|
Report No. : |
333104 |
|
Report Date : |
27.07.2015 |
IDENTIFICATION DETAILS
|
Name : |
BIOLAB SANUS FARMACÊUTICA LTDA |
|
|
|
|
Registered Office : |
Avenida Paulo Ayres,280 - Vila Iasi , 06767-220 - Taboão Da Serra/Sp |
|
|
|
|
Country : |
Brazil |
|
|
|
|
Financials (as on) : |
31.12.2011 |
|
|
|
|
Date of Incorporation : |
20.08.1978 |
|
|
|
|
Legal Form : |
Limited Liability Company |
|
|
|
|
Line of Business : |
The subject is engaged in the manufacture and sale of pharmaceuticals
in general; veterinary products, nutritional products and cosmetics in
general. |
|
|
|
|
No. of Employees : |
2000 |
RATING & COMMENTS
|
MIRA’s Rating : |
B |
|
RATING |
STATUS |
PROPOSED CREDIT LINE |
|
|
26-40 |
B |
Capability to overcome financial difficulties seems comparatively
below average. |
Small |
|
Status : |
Moderate |
|
Payment Behaviour : |
No Complaints |
|
Litigation : |
Exist |
NOTES:
Any query related to this report can be made
on e-mail: infodept@mirainform.com
while quoting report number, name and date.
ECGC Country Risk Classification List – March 31, 2015
|
Country Name |
Previous Rating (31.12.2014) |
Current Rating (31.03.2015) |
|
Brazil |
A2 |
A2 |
|
Risk Category |
ECGC
Classification |
|
Insignificant |
A1 |
|
Low |
A2 |
|
Moderate |
B1 |
|
High |
B2 |
|
Very High |
C1 |
|
Restricted |
C2 |
|
Off-credit |
D |
BRAZIL - ECONOMIC OVERVIEW
Characterized by large and well-developed agricultural,
mining, manufacturing, and service sectors, and a rapidly expanding middle
class, Brazil's economy outweighs that of all other South American countries, and
Brazil is expanding its presence in world markets. Since 2003, Brazil has
steadily improved its macroeconomic stability, building up foreign reserves,
and reducing its debt profile by shifting its debt burden toward real
denominated and domestically held instruments. Since 2008, Brazil became a net
external creditor and all three of the major ratings agencies awarded
investment grade status to its debt. After strong growth in 2007 and 2008, the
onset of the global financial crisis hit Brazil in 2008. Brazil experienced two
quarters of recession, as global demand for Brazil's commodity-based exports
dwindled and external credit dried up. However, Brazil was one of the first
emerging markets to begin a recovery. In 2010, consumer and investor confidence
revived and GDP growth reached 7.5%, the highest growth rate in the past 25
years. After reaching historic lows of 4.5% in early 2014, the unemployment
rate remains low, but is rising. Brazil's traditionally high level of income
inequality has declined for each of the last 15 years. GDP growth has slowed
since 2011, due to several factors, including: overdependence on exports of raw
commodities, low productivity, high operational costs, persistently high
inflation, and low levels of investment. Brazil’s fiscal and current account
balances have eroded during the past four years as the government attempted to
boost economic growth through targeted tax cuts for industry and incentives to
spur household consumption. After winning re-election in October 2014 by a historically
narrow margin, President Dilma ROUSSEFF appointed a new economic team led by
Finance Minister Joaquim LEVY, who introduced a fiscal austerity package
intended to restore the primary account surplus to 1.2% of GDP and preserve the
country’s investment-grade sovereign credit rating. Brazil seeks to strengthen
its workforce and its economy over the long run by imposing local content and
technology transfer requirements on foreign businesses, by investing in
education through social programs such as Bolsa Familia and the Brazil Science
Mobility Program, and by investing in research in the areas of space,
nanotechnology, healthcare, and energy.
|
Source
: CIA |
BIOLAB SANUS FARMACÊUTICA LTDA
ADDRESSES:
|
|
MAIN ADDRESS: |
AVENIDA PAULO AYRES,280 - VILA IASI |
|
ZIP CODE/CITY: |
06767-220 - TABOÃO DA SERRA/SP |
|
|
|
|
PHONE: |
11 3573-6400 |
|
FAX: |
11 3573-6400 |
|
E-MAIL: |
furias@biolabfarma.com.br |
|
WEB SITE: |
www.biolabfarma.com.br |
|
|
|
|
BRANCHES: |
|
|
|
|
|
ADDRESS: |
ALAMEDA DOS TUPINIQUINS,1125 - PLANALTO PAULISTA |
|
ZIP CODE/CITY: |
04077-003 SAO PAULO/SP |
|
|
|
|
ADDRESS: |
ESTRADA DE ITAPECERICA,23480 |
|
ZIP CODE/CITY: |
05858-004 SÃO PAULO/SP |
|
|
|
|
ADDRESS: |
RUA OMAZ GARCIA PARRA,50 |
|
ZIP CODE/CITY: |
06600-000 JANDIRA/SP |
|
CNPJ: |
494758330 |
|
|
|
|
ADDRESS: |
AV. DO CAFE,277 703 TORRE B |
|
ZIP CODE/CITY: |
04311-000 SÃO PAULO/SP |
|
|
|
|
ADDRESS: |
RUA DAS OLIMPIADAS,242 / 3º ANDAR - VILA OLIMPIA |
|
ZIP CODE/CITY: |
04551-000 SÃO PAULO/SP |
|
PHONE: |
11 3573-6000 |
|
FAX: |
11 3573-6065 |
|
CNPJ: |
49.475.833/0003-60 |
|
|
|
|
REQUESTED ADDRESS: |
RUA SOLANGE APARECIDA MONTAN,49 - JARDIM SAGRADO CORAÇÃO |
|
ZIP CODE/CITY: |
06610-015 JANDIRA/SP |
|
PHONE: |
11 3573-6600 |
|
CNPJ: |
49.475.833/0014-12 |
|
THE COMPANY ALSO HAS OTHER BRANCHES LOCATED IN: BRASILIA, RECIFE,
GOIANIA, POUSO ALEGRE AND SÃO PAULO. |
LEGAL
DATA:
|
|
MAIN ACTIVITIES: |
|
THE SUBJECT IS ENGAGED IN THE MANUFACTURE AND SALE OF PHARMACEUTICALS IN
GENERAL; VETERINARY PRODUCTS, NUTRITIONAL PRODUCTS AND COSMETICS IN GENERAL. |
|
LEGAL FORM: |
LIMITED LIABILITY COMPANY |
|
|
|
|
INCORPORATION DATE: |
20/08/1978 |
|
REGISTER DATE: |
20/08/1978 |
|
BALANCE SHEET FILING DATE: |
31/12 |
|
TAX CONTRIBUTOR NUMBER(CNPJ): |
49.475.833/0001-06 |
|
STATE REGISTER: |
675.068.451.112 |
|
|
|
|
SHARE CAPITAL: |
R$ 399.861.933,00 |
|
LAST REGISTER OF CAPITAL: |
16/07/2013 |
|
BOARD OF DIRECTORS: |
|
|
|
|
|
CLEITON DE CASTRO MARQUES |
MANAGING PARTNER |
|
DANTE ALÁRIO JÚNIOR |
MANAGING PARTNER |
|
PAULO DE CASTRO MARQUES |
MANAGER |
AUTHORIZED
USE OF SIGNATURE:
|
|
THE MANAGING PARTNERS ARE AUTHORIZED TO SIGN ON BEHALF OF THE COMPANY. |
|
SHAREHOLDERS / PARTNERS: |
|
|
|
|
|
PROVA PARTICIPAÇÕES LTDA |
R$ 150.388.073,00 |
|
CLEITON DE CASTRO MARQUES |
R$ 150.388.073,00 |
|
DANTE ALÁRIO JÚNIOR |
R$ 99.085.787,00 |
|
AFFILIATES / SUBSIDIARIES: |
|
|
A SCAN THROUGH OUTSIDE SOURCES SHOWED THE SUBJECT AND/OR DIRECTORS HAS/HAVE
THE FOLLOWING UNCONFIRMED HOLDINGS: |
|
|
MERZ-BIOLAB FARMACEUTICA
COMERCIAL LTDA. |
|
|
COINFAR - CONSORCIO DE
INDUSTRIAS FARMACEUTICAS |
|
|
COINFAR PESQUISA E
DESENVOLVIMENTO FARMACEUTICO LTDA. |
|
|
SINTEFINA INDUSTRIA E COMERCIO
LTDA |
|
|
SEDAMA S/C LTDA - ME |
|
|
ORYGEN BIOTECNOLOGIA S.A. |
|
|
AVERT LABORATORIOS LTDA. |
|
COMPANY'S
BACKGROUND:
|
|
THE SUBJECT WAS ESTABLISHED ON AUGUST 20, 1978 TO BE ENGAGED IN THE SAID
LINE OF BUSINESS AND UP TO DATE IT IS STILL OPERATING WITHIN THE GENERAL
SCENE REPORTED HEREIN. PREVIOUS CORPORATE NAMES: - MAGRITT COMERCIO REPRESENTAÇÃO E DISTRIBUIDORA DE PRODUTOS QUIMICOS
LTDA; - MAGRITT INDUSTRIA FARMACEUTICA LTDA; - SANUS FARMACEUTICA LTDA. ON NOVEMBER 11, 2013 THE COMPANY TOOK OVER BIOLAB DERMOCOSMETICOS
LTDA, CNPJ 01.539.361/0001-73. PARTNERS: PROVA PARTICIPAÇÕES LTDA, A LIMITED LIABILITY COMPANY, WITH HEAD
OFFICE AT AVENIDA DO CAFÉ 277, TORRE A, 7ª, VILA GUARANI - SÃO PAULO/SP.
HEREIN REPRESENTED BY ITS LEGAL REPRESENTATIVE MR. PAULO DE CASTRO MARQUES,
BRAZILIAN, HOLDER OF DOCUMENTS, CPF # 860.267.048-68, RG # 7556065 SSP/SP,
RESIDENTIAL ADDRESS AT AVENIDA DO CAFÉ 277, TORRE A, 7ª, VILA GUARANI - SÃO
PAULO/SP; CLEITON DE CASTRO MARQUES, BRAZILIAN, HOLDER OF DOCUMENTS, CPF #
860.267.398-15, RG # 8349370 SSP/SP, RESIDENTIAL ADDRESS AT AVENIDA DO CAFÉ
277, TORRE A, 7ª, VILA GUARANI - SÃO PAULO/SP; DANTE ALÁRIO JÚNIOR, BRAZILIAN, HOLDER OF DOCUMENTS, CPF # 295.868.108-44,
RG # 3465298 SSP/SP, RESIDENTIAL ADDRESS AT AVENIDA DO CAFÉ 277, TORRE A, 7ª,
VILA GUARANI - SÃO PAULO/SP. FURTHER DETAILS ARE SO FAR NOT KNOWN. REMARKS: -------- WHEN CONTACTING THE SUBJECT WE INTERVIEWED MR. FLAVIO - ACCOUNTING
DEPARTMENT, WHO INFORMED THAT WOULD NOT DISCLOSE ANY KIND OF INFORMATION
UNLESS THE INQUIRING PARTY'S NAME WAS DISCLOSED. IF IT IS POSSIBLE TO DISCLOSE THE NAME OF THE INTERESTED SUPPLIER OF
THE SUBJECT, WE MAY RESUME OUR CONTACTS AND TRY TO OBTAIN FURTHER
INFORMATION. THE DATA CONTAINED HEREIN WERE OBTAINED FROM OUTSIDE SOURCES, OUR
DATABASE AND OFFICIAL. NO FURTHER DATA WAS AVAILABLE WITH SEVERAL SOURCES
USUALLY INVESTIGATED. |
PUBLIC
INFORMATION:
|
|
LAWSUITS: |
|
|
|
|
DATE: |
COURT OF LAW: |
|
3 |
STATE LAWSUITS |
12/03/13 |
VARA DE DF-BRASILIA |
|
1 |
MUNICIPAL LAWSUIT |
30/09/14 |
VARA DE SP-ITAPEVI |
FINANCIAL
INFORMATION:
|
|
GENERAL BALANCE SHEETS AS OF 31/12/2011. |
|
( FIGURES ARE IN REAIS ). |
|
ASSETS |
|
|
|
|
CURRENT: |
31/12/2011 |
|
|
|
|
|
|
|
|
CASH AND BANKS |
204.519.896,65 |
|
|
|
CLIENTS |
191.201.216,44 |
|
|
|
INVENTORY |
54.314.404,80 |
|
|
|
RECOVERABLE TAXES |
1.803.511,58 |
|
|
|
CREDIT WITH RELATED PARTIES |
281.118,72 |
|
|
|
OTHER CREDITS |
2.317.592,11 |
|
|
|
PRE PAID EXPENSES |
5.359.615,79 |
|
|
|
|
---------------- |
|
|
|
TOTAL CURRENT ASSETS |
459.797.356,09 |
|
|
|
LONG-TERM RECEIVABLES: |
|
|
|
|
|
|
|
|
|
INTERCOMPANY CREDITS |
22.303.949,38 |
|
|
|
DEFERRED TAXES |
4.718.868,72 |
|
|
|
RECOVERABLE TAXES |
1.744.121,77 |
|
|
|
JUDICIAL DEPOSITS |
2.028.868,00 |
|
|
|
|
---------------- |
|
|
|
TOTAL LONG-TERM RECEIVABLES |
30.795.807,87 |
|
|
|
FIXED ASSETS: |
|
|
|
|
|
|
|
|
|
INVESTMENTS |
410.582,55 |
|
|
|
FIXED ASSETS |
93.068.327,04 |
|
|
|
INTANGIBLE |
18.720.199,25 |
|
|
|
|
---------------- |
|
|
|
TOTAL FIXED ASSETS |
112.199.108,84 |
|
|
|
|
================ |
|
|
|
TOTAL ASSETS |
602.792.272,80 |
|
|
|
LIABILITIES: |
|
|
|
|
CURRENT: |
31/12/2011 |
|
|
|
|
|
|
|
|
SUPPLIERS |
8.947.362,98 |
|
|
|
FOREIGN SUPPLIERS |
7.750.813,80 |
|
|
|
LOANS AND FINANCING |
9.070.697,48 |
|
|
|
TRIBUTARY OBLIGATIONS |
39.024.493,83 |
|
|
|
INCOME TAX/SOCIAL CONTRIBUTION |
15.311.975,96 |
|
|
|
ACCOUNTS PAYABLE |
3.402.305,76 |
|
|
|
PROFIT SHARING |
3.818.308,18 |
|
|
|
|
---------------- |
|
|
|
TOTAL CURRENT LIABILITIES |
87.325.957,99 |
|
|
|
LONG TERM LIABILITIES: |
|
|
|
|
|
|
|
|
|
LOANS AND FINANCING |
487.382,10 |
|
|
|
DEFERRED TAXES |
2.536.954,09 |
|
|
|
PROV. FOR UNCOVERED LIABILITY |
636.253,50 |
|
|
|
PROVISION FOR CONTINGENCIES |
4.593.160,96 |
|
|
|
|
---------------- |
|
|
|
TOTAL LONG TERM LIABILITIES |
8.253.750,65 |
|
|
|
NET EQUITY: |
|
|
|
|
|
|
|
|
|
SHARE CAPITAL |
422.000.100,00 |
|
|
|
CAPITAL RESERVES |
209.745,57 |
|
|
|
RESERVES FOR INVESTMENTS |
943.271,55 |
|
|
|
ACCRUED PROFIT (LOSS) |
84.059.447,04 |
|
|
|
|
---------------- |
|
|
|
TOTAL NET EQUITY |
507.212.564,16 |
|
|
|
|
================ |
|
|
|
TOTAL LIABILITIES |
602.792.272,80 |
|
|
|
PROFIT AND LOSS ACCOUNTS AS OF 31/12/2011. |
|
( FIGURES ARE IN REAIS ). |
|
|
31/12/2011 |
|
|
|
|
|
|
|
|
GROSS SALES |
661.820.826,37 |
|
|
|
(-) TAXES ON SALES |
83.027.020,82 |
|
|
|
|
---------------- |
|
|
|
NET SALES |
578.793.805,55 |
|
|
|
(-) COST OF SOLD GOODS |
129.948.023,51 |
|
|
|
|
---------------- |
|
|
|
GROSS PROFIT |
448.845.782,04 |
|
|
|
OPERATING REVENUE (EXPENSE) |
-343.954.890,80 |
|
|
|
FINANCIAL REVENUE(EXPENSE) |
21.089.517,88 |
|
|
|
|
---------------- |
|
|
|
OPERATIONAL PROFIT (LOSS) |
125.980.409,12 |
|
|
|
NON-OPERATING RESULT |
69.618,13 |
|
|
|
CONTRIBUTION/INCOME TAX |
-41.990.580,21 |
|
|
|
|
---------------- |
|
|
|
NET PROFIT (LOSS) |
84.059.447,04 |
|
|
|
RATIOS: |
31/12/2011 |
|
|
|
QUICK RATIO |
4,64 |
|
|
|
|
|
|
CURRENT RATIO |
5,27 |
|
|
|
|
|
|
ACCOUNTS RECEIVABLE TURNOVER |
3,03 |
TIMES |
|
|
|
|
|
DAYS' SALES IN RECEIVABLES |
118,92 |
DAYS |
|
|
|
|
|
INVENTORY TURNOVER |
2,39 |
TIMES |
|
|
|
|
|
ACCOUNTS PAYABLE PERIOD |
24,79 |
DAYS |
|
|
|
|
|
RETURN ON ASSETS |
,96 |
TIMES |
|
|
|
|
|
SALES TURNOVER ON NET EQUITY |
1,14 |
TIMES |
|
|
|
|
|
NET WORTH TIE-UP |
,18 |
|
|
|
|
|
|
INDEBTEDNESS |
,19 |
|
|
|
|
|
|
EQUITY RATIO |
84,14 |
% |
|
|
|
|
|
WORKING CAPITAL RATIO |
426,53 |
% |
|
|
|
|
|
GENERAL SOLVENCY |
6,31 |
|
|
|
|
|
|
RETURN ON NET EQUITY |
16,57 |
% |
|
|
|
|
|
RETURN ON SALES (PROFIT MARGIN) |
14,52 |
% |
|
|
|
|
|
GROSS PROFIT MARGIN |
77,55 |
% |
|
|
|
|
|
OPERATIONAL RESULT |
21,77 |
% |
|
|
|
|
|
SALES TURNOVER ON LIABILITIES |
6,63 |
TIMES |
|
|
|
|
|
FOREIGN CURRENCY ON ASSETS |
|
|
|
|
|
|
|
FOREIGN CURRENCY ON LIABILITIES |
|
|
|
|
|
|
|
EXCHANGE RATE: |
|
|
US$ 1,00 = R$ 3,28 |
- OFFICIAL RATE ON 23/07/2015 |
|
US$ 1,00 = R$ 1,87 |
- OFFICIAL RATE ON 31/12/2011 |
|
COMMENTS ON THE FINANCIAL INFORMATION: |
|
FOLLOWS ATTACHED WORKSHEET WITH MAIN FINANCIAL RATIOS. THE ANNUAL FIGURES AVAILABLE SHOWED A GOOD FINANCIAL STANDING. IT WAS
NOTED HIGH LIQUIDITY RATIOS AND HIGH WORKING CAPITAL, AS WELL AS LOW LEVEL OF
INDEBTEDNESS. IT ALSO SHOWS PROFITABILITY. |
|
REAL ESTATE: |
NOT AVAILABLE
|
VEHICLES: |
NOT AVAILABLE
|
MACHINES: |
NOT AVAILABLE
INSURANCE:
|
|
INSURANCE COMPANY: |
ACE SEGURADORA S/A (HEADQUARTER) |
|
COVERAGE: |
FIRE |
|
EXPIRATION: |
NOT AVAILABLE |
|
VALUE: |
R$ 50.000.000,00 |
|
|
|
|
INSURANCE COMPANY: |
ACE SEGURADORA S/A (BRANCHES) |
|
COVERAGE: |
FIRE |
|
EXPIRATION: |
NOT AVAILABLE |
|
VALUE: |
R$ 1.500.000,00 |
BANKING
REFERENCES:
|
|
|
BRANCH/PHONE: |
|
|
BANCO ITAÚ S/A |
11 3708-8558 |
|
|
BANCO DO BRASIL S/A |
11 2128-7189 |
|
|
BANCO ITAUBANK S/A |
11 3398-6053 |
|
|
BANCO SAFRA S/A |
11 3178-2205 |
|
|
REMARKS: IN BRAZIL THE BANKS ARE PROHIBITED BY LAW TO PROVIDE
INFORMATION OR ANY KIND OF COMMENTS ABOUT THEIR CLIENTS. DUE TO THIS LAW PROHIBITION
WE ARE UNABLE TO PROVIDE ANY BANKING DETAILS. ACCORDING TO THE CENTRAL BANK OF BRAZIL OFFICIAL REPORT, THE COMPANY
HAS NO RETURNED CHECKS UP TO DATE. (IN THE TERMS OF "CIRCULAR 1682
BRAZILIAN CENTRAL BANK"). DATE RESEARCHED: JULY 23, 2015. |
ACTIVITIES
COMMENTS:
|
|
THE SUBJECT IS ENGAGED IN THE MANUFACTURE AND SALE OF PHARMACEUTICALS
IN GENERAL; VETERINARY PRODUCTS, NUTRITIONAL PRODUCTS AND COSMETICS IN
GENERAL. |
|
IMPORT AND EXPORT: |
IMPORTS FROM:
|
CHINA, INDIA, GERMANY, FRANCE, AND SWITZERLAND. |
EXPORTS TO:
|
DOMINICAN REPUBLIC (THE) |
|
MAIN CLIENTS: |
|
|
|
|
|
|
|
DOMESTIC CLIENTS: |
|
|
|
AUDIFAR COML. LTDA |
|
|
|
DISTRIB. DE MED. STA. CRUZ LTDA |
|
|
|
DISTRIBUIDORA DE PRODUTOS FARMACÊUTICOS PANARELLO |
|
62 285-6633 |
|
DROGARIA SÃO PAULO S/A |
|
|
|
ITA REPRES. PROD. FARMACEUTICOS S/A |
|
|
|
MERCANTIL FARMED LTDA |
|
11 839-5600 |
|
PROFARMA DISTRIB DE PRODUTOS FARMACÊUTICOS LTDA |
|
21 450-1828 |
|
SAGRA PRODUTOS FARMACÊUTICOS |
|
16 627-2009 |
|
STAFF: |
|
|
|
THE COMPANY HAS: 2000 EMPLOYEE(S) |
CONCEPT
AND FULFILMENT:
|
|
THE SUBJECT IS AN OLD AND WELL-ESTABLISHED COMPANY, OPERATING SINCE 1978.
SO FAR IT HAS A CLEAR TRADE HISTORY AND GOOD PAYMENT BEHAVIOR. IT IS A
FAMILY-RUN COMPANY AND BOTH THE COMPANY AND THE PRINCIPALS ENJOY A FAVORABLE
REPUTATION AMONG LOCAL TRADE SOURCES. THE COMPANY HAS TRADE RELATIONS WITH SEVERAL SUPPLIERS IN BRAZIL. THE
SUPPLIERS EXTEND CREDIT FACILITIES TO THE SUBJECT IN TERMS AND AMOUNTS
ACCORDING TO THE COMPANY'S NEEDS AND SO FAR NO PAYMENT PROBLEMS ARE NOTED. THE LAWSUITS REPORTED ARE NOT RELATED WITH TRADE DEBTS. THEY ARE
RELATED TO TAX DEBTS THAT FOR ANY REASON THE COMPANY HAS NOT YET PAID.
NEVERTHELESS WE POINT OUT THAT THE SAID LAWSUITS DO NOT AFFECT THE COMPANY'S
TRADE REPUTATION. |
|
MAIN SUPPLIERS: |
|
|
|
|
|
|
|
DOMESTIC SUPPLIERS: |
|
PHONE: |
|
ALCAN PACKAGING DO BRASIL LTDA |
|
11 4075-6500 |
|
ALTEC COM. IND. TAMPAS METÁLICAS LTDA |
|
|
|
BAFEMA S/A |
|
11 5666-9088 |
|
BILLI FAMACÊUTICA LTDA |
|
11 536-3688 |
|
EUROFARMA LABORATÓRIOS LTDA |
|
11 5693-4100 |
|
FAMACAP IND. E COMERCIO LTDA |
|
11 4666-5333 |
|
GENIX IND. FARMAC. LTDA |
|
|
|
IMPACTA AS IND E COMERCIO |
|
11 4447-7322 |
|
SCHOTT VITROSUL LTDA |
|
11 4591-0246 |
|
SELECTCHEMIE IMP. E EXP. E REPRES. LTDA |
|
11 5581-6668 |
|
TUBOCAP ARTEFATOS DE METAL LTDA |
|
|
|
VEDAT TAMPAS HERMÉTICAS LTDA |
|
11 494-4266 |
|
WHEATON DO BRASIL INDUSTRIA E COMERCIO |
|
11 5584-5133 |
|
FOREIGN SUPPLIERS: |
COUNTRY: |
|
|
DIOSYNTH B.V. |
HOLLAND |
|
|
DR. REDDY S LABORATORIES LTD |
INDIA |
|
|
EFFECHEM SRL |
ITALY |
|
|
MERZ + CO GMBH & CO |
GERMANY |
|
PAYMENT
HISTORY:
|
|
36 SUPPLIERS REPORTED PAYMENTS: |
|
TOTAL AMOUNT: R$ 1.345.329,00 |
|
|
|
AMOUNT OF INVOICES PAID: 151 |
|
TOTAL OF PROMPT PAYMENTS: 99,2% |
|
TOTAL OF DELAYED PAYMENTS: 0,8% |
|
|
|
HIGHEST INVOICE: R$ 205.962,00 |
|
HIGHEST CREDIT: R$ 205.962,00 |
|
|
|
OUTSTANDING INVOICES DUE WITHIN THE NEXT 30 DAYS: |
|
--------------------------- |
SUPPLIERS: |
INVOICES: |
TOTAL AMOUNT: |
|
DUE WITHIN 30 DAYS |
4 |
7 |
R$ 4.224,65 |
FINAL
OPINION:
|
|
BASED ON THE GENERAL INFORMATION AVAILABLE IT IS BELIEVED THAT GOOD
TRADE RELATIONS MAY BE ESTABLISHED. CREDIT FACILITIES MAY BE EXTENDED WITHIN
TERMS AND AMOUNTS ADEQUATE TO THE COMPANY'S FINANCIAL STRENGTH. |
FOREIGN EXCHANGE RATES
|
Currency |
Unit
|
Indian Rupees |
|
US Dollar |
1 |
Rs.63.89 |
|
|
1 |
Rs.99.10 |
|
Euro |
1 |
Rs.70.12 |
INFORMATION DETAILS
|
Analysis Done by
: |
DIV |
|
|
|
|
Report Prepared
by : |
TPT |
RATING EXPLANATIONS
|
RATING |
STATUS |
PROPOSED CREDIT LINE |
|
|
|
>86 |
Aaa |
Possesses an extremely sound financial base with the strongest
capability for timely payment of interest and principal sums |
Unlimited |
|
|
71-85 |
Aa |
Possesses adequate working capital. No caution needed for credit
transaction. It has above average (strong) capability for payment of interest
and principal sums |
Large |
|
|
56-70 |
A |
Financial & operational base are regarded healthy. General unfavourable
factors will not cause fatal effect. Satisfactory capability for payment of
interest and principal sums |
Fairly Large |
|
|
41-55 |
Ba |
Overall operation is considered normal. Capable to meet normal
commitments. |
Satisfactory |
|
|
26-40 |
B |
Capability to overcome financial difficulties seems comparatively
below average. |
Small |
|
|
11-25 |
Ca |
Adverse factors are apparent. Repayment of interest and principal sums
in default or expected to be in default upon maturity |
Limited with full
security |
|
|
<10 |
C |
Absolute credit risk exists. Caution needed to be exercised |
Credit not
recommended |
|
|
-- |
NB |
New Business |
-- |
|
This score serves as a reference to assess SC’s
credit risk and to set the amount of credit to be extended. It is calculated
from a composite of weighted scores obtained from each of the major sections of
this report. The assessed factors and their relative weights (as indicated
through %) are as follows:
Financial
condition (40%) Ownership
background (20%) Payment
record (10%)
Credit history
(10%) Market trend (10%) Operational size
(10%)
This report is issued at your request without any
risk and responsibility on the part of MIRA INFORM PRIVATE LIMITED (MIPL) or
its officials.